Table 3.
Subgroup analyses of all-cause mortality.
| Subgroup | Studies | HR (95% CI) | p value | Heterogenicity (p value) | ||
|---|---|---|---|---|---|---|
| Total | 10 | |||||
| Patients | HD | 8 | Cheng et al.16, Bai et al.17, Liao et al.23, Zhu (2020), Chen et al.24, Takahashi et al.20, Raggi et al.25, Panuccio et al.21 | 1.553 (1.369–1.763) | < 0.001 | 0.500 |
| PD | 2 | Chen et al.24, Wang (2002) | 2.094 (1.374–3.191) | < 0.001 | 0.472 | |
| Calcified valve | AVC | 2 | Bai et al.17, Raggi et al.25 | 1.456 (1.105–1.917) | 0.008 | 0.853 |
| MVC | 2 | Bai et al.17, Raggi et al.25 | 1.752 (1.200–2.060) | < 0.001 | 0.672 | |
AVC aortic valve calcification, MVC mitral valve calcification.